

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Metaxalone
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Sun Valley Arthritis Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Metaxalone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cognitive Dysfunction.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 24, 2024
Lead Product(s) : Metaxalone
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Sun Valley Arthritis Center
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Metaxalone
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : ClinOhio Research Services, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg
Details : Metaxalone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 04, 2024
Lead Product(s) : Metaxalone
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : ClinOhio Research Services, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Metaxalone
Therapeutic Area : Musculoskeletal
Study Phase : Phase IV
Sponsor : Illumination Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
Details : Metaxalone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Sciatica.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 05, 2023
Lead Product(s) : Metaxalone
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Sponsor : Illumination Health
Deal Size : Inapplicable
Deal Type : Inapplicable
